ANIP Sale Disclosure
Lalwani Nikhil · SEC Form 4 · Filed Sep 16, 2026
Sale
Calculated transaction value
$383.4K
Lalwani Nikhil President & CEO
ANIP
ANI Pharmaceuticals
ANIP
Transaction date
Sep 15, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 1 day later
ANIP daily price context
Close on/before transaction
$72.11
Sep 15, 2026
Close before public filing
$72.11
Sep 15, 2026
Return since public filing
+8.69%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,400 shares @ $71
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001822629-26-000016
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$383.4K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ani Pharmaceuticals Inc ANIP Current | Sale | Sep 15, 2026 | $383.4K |